CD14 and Parkinson disease: Subsequent flow cytometry analysis based on CD14 and CD16 expression revealed no significant differences in the distribution of classical (CD14+CD16-), intermediate (CD14+CD16+), and non-classical (CD14dimCD16+; CD14dim denotes low amounts of CD14) monocyte subpopulations between PD patients and controls [126].